Related Experiment Videos

[Long-term prognosis after reperfusion therapy for acute myocardial infarction in elderly patients]

M Ishihara1, H Sato, T Kawagoe

  • 1Department of Cardiology, Hiroshima City Hospital.

Insights

Achieving TIMI grade 3 flow after acute myocardial infarction significantly improves survival in elderly patients, similar to younger individuals. This crucial reperfusion endpoint benefits both age groups, highlighting its importance in cardiac care.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Thrombolysis In Myocardial Infarction (TIMI) grade 3 flow is linked to better survival in non-elderly acute myocardial infarction (AMI) patients.
  • The prognostic significance of TIMI grade 3 flow in elderly AMI patients remains unclear.

Purpose of the Study:

  • To evaluate the impact of final TIMI grade 3 flow on survival in elderly patients following AMI.
  • To compare the outcomes of elderly and non-elderly patients with AMI regarding reperfusion and mortality.

Main Methods:

  • A cohort of 1,115 AMI patients undergoing coronary angiography within 24 hours were analyzed.
  • Patients were stratified into elderly (≥75 years, n=131) and non-elderly (<75 years, n=984) groups.
  • Cox proportional hazards models assessed predictors of 10-year cardiac death-free survival.

Main Results:

  • Elderly patients had higher in-hospital mortality (25% vs 9%) and lower 10-year cardiac death-free rates.
  • Final TIMI grade 3 flow was less frequent in elderly patients (53% vs 65%).
  • Final TIMI grade 3 flow independently predicted improved 10-year cardiac death-free survival in both elderly (OR 0.39) and non-elderly (OR 0.41) patients.

Conclusions:

  • Final TIMI grade 3 flow is a critical determinant of both short- and long-term survival after AMI in elderly patients.
  • These findings underscore the importance of achieving optimal reperfusion in all age groups with AMI.
  • The study supports the universal application of TIMI grade 3 flow as a therapeutic goal in AMI management.

Related Concept Videos